Pharmaceuticals (Oct 2022)

Investigation of the Mechanisms of Tramadol-Induced Seizures in Overdose in the Rat

  • Camille Lagard,
  • Dominique Vodovar,
  • Lucie Chevillard,
  • Jacques Callebert,
  • Fabien Caillé,
  • Géraldine Pottier,
  • Hao Liang,
  • Patricia Risède,
  • Nicolas Tournier,
  • Bruno Mégarbane

DOI
https://doi.org/10.3390/ph15101254
Journal volume & issue
Vol. 15, no. 10
p. 1254

Abstract

Read online

Tramadol overdose is frequently associated with the onset of seizures, usually considered as serotonin syndrome manifestations. Recently, the serotoninergic mechanism of tramadol-attributed seizures has been questioned. This study’s aim was to identify the mechanisms involved in tramadol-induced seizures in overdose in rats. The investigations included (1) the effects of specific pretreatments on tramadol-induced seizure onset and brain monoamine concentrations, (2) the interaction between tramadol and γ-aminobutyric acid (GABA)A receptors in vivo in the brain using positron emission tomography (PET) imaging and 11C-flumazenil. Diazepam abolished tramadol-induced seizures, in contrast to naloxone, cyproheptadine and fexofenadine pretreatments. Despite seizure abolishment, diazepam significantly enhanced tramadol-induced increase in the brain serotonin (p p p p 11C-flumazenil brain kinetics was observed following tramadol administration in contrast to diazepam, suggesting that the observed interaction was not related to a competitive mechanism between tramadol and flumazenil at the benzodiazepine-binding site. Our findings do not support the involvement of serotoninergic, histaminergic, dopaminergic, norepinephrine or opioidergic pathways in tramadol-induced seizures in overdose, but they strongly suggest a tramadol-induced allosteric change of the benzodiazepine-binding site of GABAA receptors. Management of tramadol-poisoned patients should take into account that tramadol-induced seizures are mainly related to a GABAergic pathway.

Keywords